Antibodies that neutralize RSV, MPV and PVM and uses thereof
US9498531B2 · kind B2 · utility
1Cited by
0References
26Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 14, 2013 |
| Grant date | Nov 22, 2016 |
| Priority date | — |
| Expiry date | Sep 6, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2760/18522
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to antibodies, and antigen binding fragments thereof, that neutralize infection of both RSV, MPV and PVM. The invention also relates to nucleic acids that encode, immortalized B cells and cultured plasma cells that produce, and to polypeptides that bind to such antibodies and antibody fragments. In addition, the invention relates to the use of the antibodies, antibody fragments, and polypeptides recognized by the antibodies of the invention in screening methods as well as in the diagnosis, treatment and prevention of RSV or MPV infection and RSV and MPV co-infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.